SuperNova Diagnostics has entered into a commercial partnership with European specialist healthcare distributor Concile to develop the point-of-care diagnostic test for assessing wellness deficiencies.
SuperNova will create and manufacture the point-of-care test product, secure regulatory approvals and co-promote the product in the European market.
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
SuperNova will retain 100% of marketing rights outside of the EU and has the ability to sub-licence or sell directly.
Concile sells and develops diagnostic products for cardiovascular, oncology, wellness, infectious disease, diabetes, metabolic and esoteric diseases.